Cochlear Ltd Asset Resilience Ratio
Cochlear Ltd asset resilience ratio. Cochlear Ltd (COH) has an Asset Resilience Ratio of 9.76% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See defensive interval ratio of Cochlear Ltd to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Cochlear Ltd (2010–2025)
Asset resilience ratio of Cochlear Ltd from 2010 to 2025. This chart shows how Cochlear Ltd's Asset Resilience Ratio has changed over time. Read Cochlear Ltd total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Cochlear Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see COH total asset value.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$275.70 Million | 9.76% |
| Short-term Investments | AU$0.00 | 0% |
| Total Liquid Assets | AU$275.70 Million | 9.76% |
Asset Resilience Insights
- Limited Liquidity: Cochlear Ltd maintains only 9.76% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Cochlear Ltd Industry Peers by Asset Resilience Ratio
Compare Cochlear Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Vitrolife AB
ST:VITR |
Medical Devices | 7.27% |
|
Sinocare Inc
SHE:300298 |
Medical Devices | 3.53% |
|
Shanghai Sanyou Medical Co Ltd
SHG:688085 |
Medical Devices | 7.69% |
|
Zhejiang Orient Gene Biotech Co Ltd
SHG:688298 |
Medical Devices | 2.82% |
|
Nanjing Vishee Medical Technology Co Ltd
SHG:688580 |
Medical Devices | 10.74% |
|
TAIDOC TECHNOLOGY CORP
TW:4736 |
Medical Devices | 23.03% |
|
Dirui Industrial Co Ltd
SHE:300396 |
Medical Devices | 3.90% |
|
Impedimed Ltd
AU:IPD |
Medical Devices | 46.15% |
Cochlear Ltd Asset Resilience Ratio by Year (2010–2025)
Cochlear Ltd asset resilience ratio by year from 2010 to 2025. The table below shows the annual Asset Resilience Ratio data for Cochlear Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-06-30 | 9.76% | AU$275.70 Million ≈ $195.08 Million |
AU$2.83 Billion ≈ $2.00 Billion |
-12.69pp |
| 2024-06-30 | 22.45% | AU$616.30 Million ≈ $436.07 Million |
AU$2.75 Billion ≈ $1.94 Billion |
-2.71pp |
| 2023-06-30 | 25.16% | AU$646.30 Million ≈ $457.30 Million |
AU$2.57 Billion ≈ $1.82 Billion |
-3.16pp |
| 2022-06-30 | 28.32% | AU$698.10 Million ≈ $493.95 Million |
AU$2.47 Billion ≈ $1.74 Billion |
+2.07pp |
| 2021-06-30 | 26.25% | AU$636.90 Million ≈ $450.65 Million |
AU$2.43 Billion ≈ $1.72 Billion |
-9.75pp |
| 2020-06-30 | 36.00% | AU$930.00 Million ≈ $658.03 Million |
AU$2.58 Billion ≈ $1.83 Billion |
+3.84pp |
| 2019-06-30 | 32.16% | AU$443.60 Million ≈ $313.88 Million |
AU$1.38 Billion ≈ $975.87 Million |
+26.53pp |
| 2018-06-30 | 5.64% | AU$65.20 Million ≈ $46.13 Million |
AU$1.16 Billion ≈ $818.58 Million |
-3.87pp |
| 2017-06-30 | 9.50% | AU$107.97 Million ≈ $76.40 Million |
AU$1.14 Billion ≈ $804.00 Million |
+8.31pp |
| 2016-06-30 | 1.20% | AU$11.45 Million ≈ $8.10 Million |
AU$957.36 Million ≈ $677.40 Million |
+0.76pp |
| 2015-06-30 | 0.44% | AU$3.85 Million ≈ $2.73 Million |
AU$875.40 Million ≈ $619.40 Million |
+0.41pp |
| 2010-06-30 | 0.03% | AU$204.00K ≈ $144.34K |
AU$751.72 Million ≈ $531.89 Million |
-- |
About Cochlear Ltd
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. The company offers cochlear implant systems, sound processor upgrades, bone conduction systems, and other products. It also provides cochlear nucleus systems, including Nucleus sound processors, smart bimodal hearing solution, and Nucleus implants; cochlear Baha systems comprising Baha 6 max sound processor… Read more